Pratt Collard Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History

Pratt Collard Advisory Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$350K	Sell	2,140 -25	-1%	-$3.85K	0.23%	78
2021 Q1	$326K	Hold	2,165	–	–	0.23%	78
2020 Q4	$328K	Sell	2,165 -150	-6%	-$21.4K	0.24%	76
2020 Q3	$313K	Buy	2,315 +150	+7%	+$20.3K	0.26%	74
2020 Q2	$296K	Sell	2,165 -10	-0.5%	-$1.27K	0.27%	73
2020 Q1	$234K	Hold	2,175	–	–	0.24%	77
2019 Q4	$262K	Sell	2,175 -150	-6%	-$16.7K	0.2%	87
2019 Q3	$231K	Hold	2,325	–	–	0.18%	94
2019 Q2	$254K	Sell	2,325 -600	-21%	-$63.8K	0.2%	91
2019 Q1	$327K	Sell	2,925 -5	-0.2%	-$548	0.26%	81
2018 Q4	$283K	Hold	2,930	–	–	0.26%	84
2018 Q3	$357K	Hold	2,930	–	–	0.29%	84
2018 Q2	$322K	Sell	2,930 -120	-4%	-$12.8K	0.28%	88
2018 Q1	$326K	Sell	3,050 -265	-8%	-$29.4K	0.28%	86
2017 Q4	$354K	Buy	+3,315	New	+$354K	0.29%	86

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pratt Collard Advisory Partners's IBB Position: Q2 2021 in Review

Pratt Collard Advisory Partners reduced its iShares Biotechnology ETF (IBB) stake by 1.2% in Q2 2021, selling an estimated $3.85K and leaving 2,140 shares worth $350K. The position accounts for 0.23% of the portfolio, ranked #78.

Pratt Collard Advisory Partners first reported a position in IBB in Q4 2017 and has held it in 15 quarters since. The position peaked at $357K in Q3 2018. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

Pratt Collard Advisory Partners held 2,140 shares of iShares Biotechnology ETF worth $350K as of Q2 2021.
Pratt Collard Advisory Partners sold 25 iShares Biotechnology ETF shares in Q2 2021, an estimated $3.85K.
iShares Biotechnology ETF made up 0.23% of Pratt Collard Advisory Partners's portfolio in Q2 2021, its #78 holding.
Pratt Collard Advisory Partners first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 15 quarters since.
Pratt Collard Advisory Partners's iShares Biotechnology ETF position peaked at $357K in Q3 2018.
863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2021, filed 14 Jul 2021.